Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide and it is primarily caused by acute plaque disruption and coronary occlusion. Recent studies suggest that myocardial infarction with non-obstructive coronary arteries (MINOCA) also occurs but the underlying mechanisms have not been fully understood until recently. The evidence also suggests that the clinical outcomes of patients presenting with MINOCA are similar to AMI patients with obstructive coronary artery disease (MI-CAD), including all-cause mortality and major adverse cardiovascular events. The present narrative review considers the risk factors, pathological changes, and outcomes associated with MINOCA and compares them with MI-CAD.
CilibertiGCompagnucciPUrbinatiA, et al.Myocardial Infarction Without Obstructive Coronary Artery Disease (MINOCA): a practical guide for clinicians. Curr Probl Cardiol. 2021;46:100761.
3.
BeltrameJF. Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA). J Intern Med. 2013;273:182-185.
4.
ThygesenKAlpertJSJaffeAS, et al.Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618-e651.
5.
SmilowitzNRMahajanAMRoeMT, et al.Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION Registry-GWTG (Acute coronary treatment and intervention outcomes network registry-get with the guidelines). Circ Cardiovasc Qual Outcomes. 2017;10:e003443.
6.
PasupathySAirTDreyerRPTavellaRBeltrameJF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131:861-870.
7.
Tamis-HollandJEJneidHReynoldsHR, et al.Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American heart association. Circulation. 2019;139:e891-e908.
8.
PaolissoPFoaABergamaschiL, et al.Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovasc Diabetol. 2021;20:192.
9.
IshiiMKaikitaKSakamotoK, et al.Characteristics and in-hospital mortality of patients with myocardial infarction in the absence of obstructive coronary artery disease in super-aging society. Int J Cardiol. 2020;301:108-113.
10.
PaisJLIzquierdo CoronelBGalán GilD, et al.Psycho-emotional disorders as incoming risk factors for myocardial infarction with non-obstructive coronary arteries. Cardiol J. 2018;25:24-31.
11.
GuXHHeCJShenLHanB. Association between depression and outcomes in chinese patients with myocardial infarction and nonobstructive coronary arteries. J Am Heart Assoc. 2019;8:e011180.
12.
GhiadoniLDonaldAECropleyM, et al.Mental stress induces transient endothelial dysfunction in humans. Circulation. 2000;102:2473-2478.
13.
HjortMEggersKMLindhagenL, et al.Increased inflammatory activity in patients 3 months after myocardial infarction with nonobstructive coronary arteries. Clin Chem. 2019;65:1023-1030.
14.
AbduFALiuLMohammedAQ, et al.Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: Clinical features, treatment and 1 year follow-up. Int J Cardiol. 2019;287:27-31.
15.
PasupathySLindahlBLitwinP, et al.Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA global collaboration. Circ Cardiovasc Qual Outcomes. 2021;14:e007880.
16.
CilibertiGVerdoiaMMerloM, et al.Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): insights from a multicentre national registry. Int J Cardiol. 2021;327:9-14.
17.
CilibertiGCoiroSTrittoI, et al.Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA). Int J Cardiol. 2018;267:41-45.
18.
DreyerRPTavellaRCurtisJP, et al.Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population. Eur Heart J. 2020;41:870-878.
19.
ChooEHChangKLeeKY, et al.Prognosis and predictors of mortality in patients suffering myocardial infarction with non-obstructive coronary arteries. J Am Heart Assoc. 2019;8:e011990.
20.
GasiorPDesperakAGierlotkaM, et al.Clinical Characteristics, Treatments, and Outcomes of Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Results from a Multicenter National Registry. J Clin Med. 2020;9:2779.
21.
EggersKMHjortMBaronT, et al.Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries. J Intern Med. 2019;285:419-428.
22.
SafdarBSpatzESDreyerRP, et al.Presentation, clinical profile, and prognosis of young patients with Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): results from the VIRGO study. J Am Heart Assoc. 2018;7:e009174.
23.
PlanerDMehranROhmanEM, et al.Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ Cardiovasc Interv. 2014;7:285-293.
24.
Lopez-PaisJIzquierdo CoronelBGalan GilD, et al.Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA): A prospective single-center study. Cardiol J. 2020 doi: 10.5603/CJ.a2020.0146. Online ahead of print.
25.
MagnaniGBricoliSArdissinoM, et al.Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA). Int J Cardiol. 2022;354:7-13.
26.
SudaATakahashiJBeltrameJF, et al.International prospective cohort study of microvascular angina - Rationale and design. Int J Cardiol Heart Vasc. 2020;31:100630.
27.
CreaFCamiciPGBairey MerzCN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101-1111.
28.
WaheedNElias-SmaleSMalasW, et al.Sex differences in non-obstructive coronary artery disease. Cardiovasc Res. 2020;116:829-840.
29.
SmithLRSalifuMOMcFarlaneIM. Non-Obstructive Coronary Artery Disease in Women: Current Evidence and Future Directions. Int J Clin Res Trials. 2020;5:15.
30.
MauricioRSrichaiMBAxelLHochmanJSReynoldsHR. Stress cardiac MRI in women with myocardial infarction and nonobstructive coronary artery disease. Clin Cardiol. 2016;39:596-602.
31.
De VitaAManfredoniaLLamendolaP, et al.Coronary microvascular dysfunction in patients with acute coronary syndrome and no obstructive coronary artery disease. Clin Research Cardiol: Official J German Cardiac Soc. 2019;108:1364-1370.
32.
RadicoFGallinaSZimarinoM. Is coronary microvascular dysfunction a cause or a marker of worse outcomes in MINOCA patients?Eur J Intern Med. 2021;92:38-39.
33.
AbduFALiuLMohammedAQ, et al.Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries. Eur J Intern Med. 2021;92:79-85.
34.
RizzoniDPalomboCPorteriE, et al.Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens. 2003;21:625-631.
35.
MomoseMAbletshauserCNeverveJ, et al.Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus. Eur J Nucl Med Mol Imag. 2002;29:1675-1679.
36.
YokoyamaIOhtakeTMomomuraSNishikawaJSasakiYOmataM. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 1996;94:3232-3238.
37.
RooksCFaberTVotawJ, et al.Effects of smoking on coronary microcirculatory function: a twin study. Atherosclerosis. 2011;215:500-506.
38.
ZanattaEColomboCD’AmicoGd’HumieresTDal LinCTonaF. Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases. Int J Mol Sci. 2019;20:5563.
39.
VaccarinoVBadimonLBremnerJD, et al.Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J. 2020;41:1687-1696.
40.
ZiadiMCDekempRAWilliamsKA, et al.Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740-748.
41.
MurthyVLNayaMTaquetiVR, et al.Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518-2527.
42.
YoonSJKimTSSeungKB, et al.Role of depressive symptoms in coronary artery spasm. Psychother Psychosom. 2010;79:191-193.
43.
MontoneRANiccoliGFracassiF, et al.Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J. 2018;39:91-98.
44.
SeitzAGardezyJPirozzoloG, et al.Long-term follow-up in patients with stable angina and unobstructed coronary arteries undergoing intracoronary acetylcholine testing. JACC Cardiovasc Interv. 2020;13:1865-1876.
45.
BaekJYChoiBGRhaSW, et al.Comparison of two-year outcomes of acute myocardial infarction caused by coronary artery spasm versus that caused by coronary atherosclerosis. Am J Cardiol. 2019;124:1493-1500.
46.
SuedaSKohnoHFukudaH, et al.Limitations of medical therapy in patients with pure coronary spastic angina. Chest. 2003;123:380-386.
47.
OkumuraKYasueHMatsuyamaK, et al.Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol. 1996;27:45-52.
48.
OuldzeinHElbazMRoncalliJ, et al.Plaque rupture and morphological characteristics of the culprit lesion in acute coronary syndromes without significant angiographic lesion: analysis by intravascular ultrasound. Ann Cardiol Angeiol. 2012;61:20-26.
49.
ReynoldsHRSrichaiMBIqbalSN, et al.Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414-1425.
50.
GerbaudEArabuckiFNivetH, et al.OCT and CMR for the diagnosis of patients presenting with MINOCA and suspected epicardial causes. JACC Cardiovasc Imaging. 2020;13:2619-2631.
51.
ReynoldsHRMaeharaAKwongRY, et al.Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation. 2021;143:624-640.
52.
OikonomouELeopoulouMTheofilisP, et al.A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications. Atherosclerosis. 2020;309:16-26.
53.
HorieTSekiguchiMHirosawaK. Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. Br Heart J. 1978;40:153-161.
54.
LindahlBBaronTErlingeD, et al.Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation. 2017;135:1481-1489.
55.
XingLYamamotoESugiyamaT, et al.EROSION study (Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion): a 1-year follow-up report. Circ Cardiovasc Interv. 2017;10:e005860.
56.
AdamsCSawhneyGSinghK. Comparing pharmacotherapy in MINOCA versus medically managed obstructive acute coronary syndrome. Heart Ves. 2022;37:705-710.
57.
PittsRDaughertySLTangF, et al.Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry. Clin Cardiol. 2017;40:347-355.
58.
SerpytisRMajauskieneENavickasP, et al.Randomized pilot trial on optimal treatment strategy, myocardial changes, and prognosis of patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA). Am J Med. 2022;135:103-109.
59.
RampidisGPKampaktsisPKouskourasK, et al.Role of cardiac CT in the diagnostic evaluation and risk stratification of patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): rationale and design of the MINOCA-GR study. BMJ Open. 2022;12:e054698.
60.
DemirelliSKATMTasolarHCalapkorurBErgunGDemirciE. Assessment of a new electrocardiographic marker for the diagnosis of myocardial infarction with non-obstructive coronary arteries. Angiology. 2022:33197221089373. doi: 10.1177/00033197221089373.
61.
ChowEDiepBGetmanT, et al.Clinical presentation and management of myocardial infarction with nonobstructive coronary arteries (MINOCA): A literature review. Heliyon. 2021;7:e08362.
62.
Lopez-PaisJIzquierdo CoronelBRaposeiras-RoubínS, et al.Differences between takotsubo and the working diagnosis of myocardial infarction with nonobstructive coronary arteries. Front Cardiovasc Med. 2022;9:742010.
